Viewing Study NCT04621318


Ignite Creation Date: 2025-12-25 @ 4:52 AM
Ignite Modification Date: 2025-12-26 @ 3:53 AM
Study NCT ID: NCT04621318
Status: COMPLETED
Last Update Posted: 2022-11-28
First Post: 2020-11-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity Study of SB16 in Healthy Male Subjects
Sponsor: Samsung Bioepis Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module